Vertical targeting of the PI3K/AKT pathway at multiple points is synergistic and effective for non-Hodgkin lymphoma.

MLA

Kupcova, Kristyna, et al. “Vertical Targeting of the PI3K/AKT Pathway at Multiple Points Is Synergistic and Effective for Non-Hodgkin Lymphoma.” Experimental Hematology & Oncology, vol. 13, no. 1, Nov. 2024, pp. 1–6. EBSCOhost, https://doi.org/10.1186/s40164-024-00568-6.

APA

Kupcova, K., Senavova, J., Jura, F., Herman, V., Rajmonova, A., Pacheco-Blanco, M., Chrbolkova, T., Hamova, I., Davis, R. E., & Havranek, O. (2024). Vertical targeting of the PI3K/AKT pathway at multiple points is synergistic and effective for non-Hodgkin lymphoma. Experimental Hematology & Oncology, 13(1), 1–6. https://doi.org/10.1186/s40164-024-00568-6

Chicago

Kupcova, Kristyna, Jana Senavova, Filip Jura, Vaclav Herman, Anezka Rajmonova, Mariana Pacheco-Blanco, Tereza Chrbolkova, Iva Hamova, R. Eric Davis, and Ondrej Havranek. 2024. “Vertical Targeting of the PI3K/AKT Pathway at Multiple Points Is Synergistic and Effective for Non-Hodgkin Lymphoma.” Experimental Hematology & Oncology 13 (1): 1–6. doi:10.1186/s40164-024-00568-6.